Nirman Agri Genetics Ltd Q3 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Published 11 Aug 2026 | Agricultural Food & other Products | Market Cap: ₹27 Cr

Nirman Agri Genetics targets a revenue growth of 150% to 200% annually for the next 5 years. Revenue growth guidance is strong, targeting 150% to 200% growth annually over the next five years.

From Nirman Agri Genetics Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Price

₹29

Market Cap

₹27 Cr

P/E Ratio

1.5

How does Nirman Agri Genetics Ltd rank in Agricultural Food & other Products?

Compare Nirman Agri Genetics Ltd against every Agricultural Food & other Products company this quarter on revenue, margins and earnings-call signals.

View Agricultural Food & other Products leaderboard →

📊 Revenue & Sales Performance

→Nirman Agri Genetics targets a revenue growth of 150% to 200% annually for the next 5 years.
→Current revenue stands at INR173 crores, with guidance to reach INR220-250 crores in FY25.
→Expected revenue:
→ - INR432 crores in two years
→ - INR1,000 crores in the next two years
→ - Approximately INR2,000 crores in five years
→No plan to reach INR20,000 crores by 2030 (clarified miscalculation).
→Growth driven by expanding market share, increased production capacity from own processing plant, and new initiatives like Krushi Dham physical stores.
→Operating margins expected to improve to 14%-15% with full utilization of new processing facility.
→Growth will be sustainable and spread throughout the year despite seasonality.

📈 Profitability & Margins

→Revenue growth guidance is strong, targeting 150% to 200% growth annually over the next five years.
→The company expects to grow from around INR 200 crores currently to INR 2,000 crores in revenue within five years.
→Net profit margins are projected to improve, aiming for 14-15% PAT margins, up from current 10-11%.
→Full utilization of the company's own processing plant is expected to contribute to margin expansion in upcoming periods.
→Q3 FY25 revenue rose 223% YoY, and net profit increased 114% YoY, signaling operational scalability and strong earnings potential.
→No immediate fundraising planned; capital allocation will depend on future situation as the company scales.
→Earnings per share (EPS) is expected to benefit from the growth in revenues and margins, reflecting sustainable profitability improvements.

🏗️ Capital Expenditure Plans

→The company has made a capex of about INR 3.5 crores for their factory.
→The factory has a revenue potential of INR 500 crores with an expected PAT margin of around 15%.
→No specific future capex plans were explicitly mentioned for new factories or expansions.
→For the planned growth to INR 2,000 crores revenue in the next five years, no current fundraising or investment plans are in place; decisions will be made based on the situation at that time.
→Krushi Dham physical stores are planned as a strategic initiative, with about 25 stores targeted initially, dependent on certifications and licensing.
→The company aims to focus on certifications, licensing, and corporate governance improvements to support future growth.

💰 Fundraising & Capital Structure

→Currently, Nirman Agri Genetics Limited has no immediate plans for fundraising through debt or equity.
→Decisions on fundraising will be made depending on the situation at the relevant time.
→The company is focused on its growth strategy and prefers to take fundraising decisions based on need as they scale.
→There is no ongoing fundraising activity announced as of the February 27, 2025 conference call.

📋 Order Book & Pipeline

→Current order book for Kharif season: INR 150 crores (unexecuted orders as of February 2025).
→Current order book for Rabi season: INR 98 crores.
→Combined order book (Kharif + Rabi): INR 248 crores approximately.
→Order book expected to increase by April 2025.
→Company standing on INR 173 crores revenue for 9 months FY25.
→Expected to meet guidance of INR 220-250 crores revenue for full FY25.
→Strong revenue growth indicating timely execution of order book.

Key Metrics

Frequently Asked Questions

What were Nirman Agri Genetics Ltd Q3 FY25 results?

Nirman Agri Genetics targets a revenue growth of 150% to 200% annually for the next 5 years. Revenue growth guidance is strong, targeting 150% to 200% growth annually over the next five years.

What is Nirman Agri Genetics Ltd share price analysis?

Nirman Agri Genetics Ltd currently shows a neutral. The stock trades at a P/E of 1.5 with a market cap of ₹27 Cr. Investors should review the full earnings analysis for detailed insights.

Is Nirman Agri Genetics Ltd planning capital expenditure?

The company has made a capex of about INR 3.5 crores for their factory.

Keep Nirman Agri Genetics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.